Related references
Note: Only part of the references are listed.Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg)
Olga P. Nyssen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
Three-Decade Failure to the Eradication of Refractory Helicobacter pylori Infection and Recent Efforts to Eradicate the Infection
Majid Taati Moghadam et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2021)
Influence of adding vitamin D3 to standard clarithromycin-based triple therapy on the eradication rates of Helicobacter pylori infection
Mohamed S. El Shahawy et al.
ARAB JOURNAL OF GASTROENTEROLOGY (2021)
The Role of Statins on Helicobacter pylori Eradication: Results from the European Registry on the Management of H. pylori (Hp-EuReg)
Maria Caldas et al.
ANTIBIOTICS-BASEL (2021)
Atorvastatin in combination with conventional antimicrobial treatment of Helicobacter pylori eradication: A randomized controlled clinical trial
Seyed Saeed Sarkeshikian et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)
Potential impact of Helicobacter pylori-related metabolic syndrome on upper and lower gastrointestinal tract oncogenesis
Jannis Kountouras et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2018)
Comment on Effect of biofilm formation by clinical isolates of Helicobacter pylori on the efflux-mediated resistance to commonly used antibiotics
Evangelos I. Kazakos et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Statin Use Reduces Risk of Esophageal Adenocarcinoma in US Veterans With Barrett's Esophagus: A Nested Case-Control Study
Theresa Nguyen et al.
GASTROENTEROLOGY (2015)